Understanding how the immune system responds to the respiratory virus HMPV is crucial for developing vaccines and anti-viral treatments.

Augmenting the signals of natural “endocannabinoids” in the brain may be a promising approach for treating mood and anxiety disorders.

A newly identified receptor allows mammalian reovirus to infect neurons, shedding light on factors important for viral encephalitis.

Understanding how to control the generation of regulatory T cells could have important implications for treating autoimmunity and cancer.

The factor ATF4 has a role in the toughness of bone and its resistance to fracture, suggesting new therapeutic targets.

New views of how transporters move molecules across cell membranes are key to understanding how these proteins impact tumor cell drug resistance and inherited diseases such as cystic fibrosis.

Virus-like particles containing a protein from human metapneumovirus are a promising vaccine candidate for this respiratory virus.